Adage Capital Partners’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Adage Capital Partners’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-44,541	Closed	-$840K	–	1018
2023 Q1	$840K	Sell	44,541 -75,000	-63%	-$1.74M	﹤0.01%	805
2022 Q4	$2.95M	Buy	119,541 +69,541	+139%	+$2.04M	0.01%	791
2022 Q3	$898K	Buy	+50,000	New	+$901K	﹤0.01%	895
2022 Q2	–	Sell	-1,154,348	Closed	-$25.7M	–	1190
2022 Q1	$25.7M	Buy	1,154,348 +500,000	+76%	+$12.8M	0.05%	387
2021 Q4	$28.6M	Buy	654,348 +354,348	+118%	+$14.2M	0.05%	358
2021 Q3	$9.99M	Buy	+300,000	New	+$9.13M	0.02%	684

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Adage Capital Partners's INBX Position: Q2 2023 in Review

Adage Capital Partners sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2023, closing a stake of 44,541 shares — an estimated $840K sold.

Adage Capital Partners first reported a position in INBX in Q3 2021 and held it in 6 quarters. The position peaked at $28.6M in Q4 2021. 107 funds tracked by Wall St. Rank hold INBX as of Q2 2023.

Adage Capital Partners reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Adage Capital Partners sold 44,541 Inhibrx, Inc. Common Stock shares in Q2 2023, an estimated $840K.
Adage Capital Partners first reported a position in Inhibrx, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
Adage Capital Partners's Inhibrx, Inc. Common Stock position peaked at $28.6M in Q4 2021.
107 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2023.

Based on Adage Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.